2023

1. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes

   The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106

2. Germline heterozygous exons 8–11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding?

   Hereditary Cancer in Clinical Practice, Vol. 21, Núm. 1